tiprankstipranks
Advertisement
Advertisement

AMGN Stock Latest News

CodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors
Company AnnouncementsCodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors
16h ago
AMGN
Trial used to approve Amgen’s Tavneos retracted from NEJM
PremiumThe Fly
Trial used to approve Amgen’s Tavneos retracted from NEJM
2d ago
AMGN
Why Schwab U.S. Dividend Equity ETF (SCHD) Could Jump 15%, According to AI
PremiumMarket News
Why Schwab U.S. Dividend Equity ETF (SCHD) Could Jump 15%, According to AI
5d ago
MRK
UNH
Midday Fly By: Micron reports blowout Q3, Apple boosts MacBook prices
PremiumThe Fly
Midday Fly By: Micron reports blowout Q3, Apple boosts MacBook prices
6d ago
BB
GS
FDA works to pull Amgen’s Tavneos off the market, Bloomberg says
PremiumThe Fly
FDA works to pull Amgen’s Tavneos off the market, Bloomberg says
6d ago
AMGN
Amgen price target raised to $303 from $295 at Mizuho
PremiumThe FlyAmgen price target raised to $303 from $295 at Mizuho
15d ago
AMGN
Amgen’s ABP 938 Takes Aim at EYLEA HD in High-Stakes Eye Disease Trial
Premium
Company Announcements
Amgen’s ABP 938 Takes Aim at EYLEA HD in High-Stakes Eye Disease Trial
19d ago
AMGN
Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market
Premium
Company Announcements
Amgen’s MARITIME-SWITCH Trial Targets GLP-1 Switchers in the Growing Obesity Drug Market
20d ago
AMGN
Amgen price target raised to $340 from $332 at Morgan Stanley
PremiumThe Fly
Amgen price target raised to $340 from $332 at Morgan Stanley
21d ago
AMGN
Climb Bio initiated with a Buy at Guggenheim
PremiumThe Fly
Climb Bio initiated with a Buy at Guggenheim
23d ago
AMGN
CLYM
Amgen announces data at ADA Scientific Sessions on cardiometabolic conditions
PremiumThe Fly
Amgen announces data at ADA Scientific Sessions on cardiometabolic conditions
23d ago
AMGN
Amgen price target lowered to $389 from $425 at Goldman Sachs
PremiumThe Fly
Amgen price target lowered to $389 from $425 at Goldman Sachs
26d ago
AMGN
European Commission approves Amgen’s Imdylltra for ES-SCLC
PremiumThe FlyEuropean Commission approves Amgen’s Imdylltra for ES-SCLC
29d ago
AMGN
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
Premium
Company Announcements
Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study
1M ago
AMGN
Amgen Shareholders Reaffirm Board, Pay and Auditors
Premium
Company Announcements
Amgen Shareholders Reaffirm Board, Pay and Auditors
1M ago
8K
AMGN
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
PremiumCompany Announcements
Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer
1M ago
AMGN
Amgen Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Amgen Earnings Call Highlights Growth Amid Headwinds
1M ago
AMGN
Amgen Announces CFO Transition and Leadership Succession Plan
PremiumCompany Announcements
Amgen Announces CFO Transition and Leadership Succession Plan
1M ago
8K
AMGN
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
PremiumThe Fly
Amgen CFO Peter Griffith to retire, Thomas Dittrich to succeed
1M ago
AMGN
Amgen price target lowered to $427 from $432 at Piper Sandler
PremiumThe FlyAmgen price target lowered to $427 from $432 at Piper Sandler
2M ago
AMGN
The Week That Was, The Week Ahead: Macro and Markets, May 10
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, May 10
2M ago
F
V
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
Premium
Market News
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
2M ago
BLK
IBB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >